Bridgepoint Group plc (LON:BPT - Get Free Report) reached a new 52-week high on Friday . The company traded as high as GBX 309.80 ($4.03) and last traded at GBX 302 ($3.92), with a volume of 245571 shares trading hands. The stock had previously closed at GBX 300.40 ($3.90).
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on BPT shares. JPMorgan Chase & Co. raised shares of Bridgepoint Group to an "overweight" rating and lifted their price target for the company from GBX 259 ($3.37) to GBX 358 ($4.65) in a research note on Tuesday, August 13th. Jefferies Financial Group reiterated a "buy" rating and issued a GBX 310 ($4.03) target price on shares of Bridgepoint Group in a research report on Tuesday, July 9th.
Read Our Latest Stock Analysis on BPT
Bridgepoint Group Price Performance
The company has a debt-to-equity ratio of 14.55, a quick ratio of 3.60 and a current ratio of 4.98. The stock's 50-day moving average is GBX 259.74 and its two-hundred day moving average is GBX 251.37. The stock has a market cap of £2.39 billion, a PE ratio of 3,775.00, a PEG ratio of 0.61 and a beta of 1.72.
Bridgepoint Group Increases Dividend
The business also recently announced a dividend, which will be paid on Monday, October 28th. Investors of record on Thursday, September 19th will be given a GBX 4.60 ($0.06) dividend. This represents a dividend yield of 1.67%. This is an increase from Bridgepoint Group's previous dividend of $4.40. The ex-dividend date is Thursday, September 19th. Bridgepoint Group's dividend payout ratio (DPR) is 11,250.00%.
About Bridgepoint Group
(
Get Free Report)
Bridgepoint Group plc is private equity and private credit firm specializing in middle market, lower mid cap, small cap, growth capital and buyouts investment. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bridgepoint Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bridgepoint Group wasn't on the list.
While Bridgepoint Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
